Radhika Gogoi

Radhika Gogoi

Radhika Gogoi

Position Title

Associate Professor - Clinical
Gynecologic Oncology

Office Location

 

Karmanos Cancer Institute
Harper Professional Building
4100 John R., HP07GO
Detroit, MI 48201

 

 

 

 

Mailing Address

Karmanos Cancer Institute
4100 John R., HP07GO
Detroit, MI 48201

 

 

Office Phone

 313-576-9438

 

Education Training

Education

(2005) PhD, University of Colorado Health Sciences Center, Denver, CO
(1996) MD, Hahnemann University School of Medicine, Philadelphia, PA
(1992) Bachelor of Science, Gannon University, Erie, PA

Postgraduate Training

(2005 - 2008) Gynecologic Oncology Fellowship, New York University, New York, NY
(1996 - 2000) Obstetrics & Gynecology Residency, University of Rochester, Rochester, NY
(1996 - 1997) Internship, University of Rochester, Rochester, NY

 

 

 

Professional Experience

Faculty Appointments

(2019 - Present) Associate Professor - Clinical, Department of Oncology, Division of Gynecologic Oncology, Wayne State University School of Medicine, Detroit, MI
(2018-2019) Associate Professor, Geisinger Commonwealth School of Medicine, Scranton, PA
(2015-2018) Clinical Assistant Professor - Adjunct, Temple University School of Medicine, Philadelphia, PA

Hospital and Other Professional Appointments

(2010-2019) Clinician Investigator, Geisinger Medical Center, Danville, PA
(2008-2010) Gynecologic Oncologist, Lankenau Institute for Medical Research & Lankenau Hospital, Wynnewood, PA
(2005-2008) Attending Physician, Obstetrics & Gynecology, University of Colorado, Denver, CO

 

 

 

Major Professional Societies

(2018 - Present) International Gynecological Cancer Society
(2005 - Present) Society for Gynecologic Oncology
(2003 - Present) American College of Obstetrics and Gynecology
(2011 - 2013) American Society for Clinical Oncology
 

 

Honors and Awards

(2017) Press Ganey 90% Patient Satisfaction Award Geisinger Medical Center
(2017) Partners in Leadership Program, Geisinger Medical Center
(2016-2017)Leadership Education and Development Certificate Program fellow AAMC
 

 

Publications

Peer-Reviewed Publications

Reports of Original Work

1. Shivkumar, M., Miller J*., Dasari, V., Gogoi, R., Kim, D., Exome-wide rare variant analysis from the DiscovEHR study identifies novel candidate predisposition genes for endometrial cancer. Frontiers in Oncology (manuscript in press). *Postdoctoral fellow
Role: study conception, design, data analysis, manuscript writing.

2. Edwards, T.L., Giri, A., Hellwege J.N., Hartmann K.E., Stewart, E.A., Jeff, J.M., Bray M., Pendergrass S., Torstenson E.S., Keaton J.M., Jone S., Gogoi, R.P., Kuivaniemi H., Jackson K., Kho, A., KullomI., McCarty C., Im, H., Pacheco, J., Pathak J., Williams M., Tromp G., Kenny E., Peissig P., Denny J., Roden D., Edwards D. A trans-ethnic genome wide association study of uterine fibroids. Frontiers in Genetics. 2019 Jun 12; 10:511. PMID: 31249589
Role: data analysis, manuscript writing.

3. Miller, J.*, Metpally, R., Person T., Krishnamurthy, S., Dasari VR., Shivkumar M., Lavage D., Cook A., VCarey D., Ritchie M., Kim, D., Gogoi, RP. Systematic characterization of germline variants from the DiscovEHR study Endometrial Carcinoma population. BMC Medical Genomics. 2019 May3; 12(1). PMID: 31118041. *Postdoctoral fellow
Role: study conception, design, implementation, data analysis, manuscript writing.

4. Bang, G., Dasari, VR., Kim D., Gogoi, RP. Differential gene expression induced by Verteporfin in endometrial cancer cells. Scientific Reports. 2019 9:3839. PMID: 30846786
Role: study conception, design, implementation (including patient recruitment), data analysis, manuscript writing.

5. Rahm, AK., Cragun D., Hunter, JE., Epstein, MM., Lowery, J., Lu ,CY., Pawloski, PA., Sharaf RN., Liang SY., Burnett-Hartman AN., Gudgeon JM., Snyder S., Gogoi, R.P. Ladd I., Williams MS. Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify organizational strategies to implement, adapt and sustain genomic medicine programs in different organizational contexts. BMC Health Serv Res. 2018 18:824. PMID: 30376847.
Role: study conception, design, implementation (including patient recruitment), data
analysis, manuscript writing.

6. Gogoi RP., Nash JD., Welshans K.*, Sun H., Smith AL. Intraoperative acetaminophen reduces the postoperative length of stay in patients undergoing robotic assisted surgery for endometrial cancer. Obstetrics and Gynecology: open access (in press) *Ob/Gyn resident
Role: study conception, design, implementation (including patient recruitment), data analysis, manuscript writing.

7. Ladd I., Gogoi RP., Larson S. Cervical cancer patients’ willingness and ability to serve as health care educators to advocate for human papillomavirus vaccine uptake. JCED 2019. Jun; 34(3):608-613. PMID: 29574539.
Role: study conception, design, implementation (including patient recruitment), data analysis, manuscript writing.

8. Zhou Y., Cartmel B., Gottlieb, L., Ercolano E., Li F., Harrigan M., McCorkle R., Ligibel J., von Gruenigen V., Gogoi R., Schwartz P., Risch H., Irwin M. Randomized trial of exercise on quality of life and fatigue in ovarian cancer: The Women’s Activity and Lifestyle Study in Connecticut (WALC). JNCI (2017) 109 (12). PMID: 30053074
Role: study conception, design, implementation (including patient recruitment), data analysis, manuscript writing.

9. Dasari V., Mazack V., Feng W., Nash J., Carey D., Gogoi R. Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells. Oncotarget 2017 Apr 25; 8 (17):28628-28640. PMID: 28404908.
Role: study conception, design, implementation (including patient recruitment), data analysis,
manuscript writing.

10. Tsujiura M., Mazack V., Sudol M., Kaspar J., Carey D., Gogoi R. (2014) Yes-associated protein (YAP) modulates oncogenic features and radiation sensitivity in endometrial cancer. PloS One Jun 27; 9(6):e100974. PMID: 24972085.
Role: study conception, design, implementation (including patient recruitment), data analysis,
manuscript writing.

11. Feng W., Yan X., Colonie R., Prichard J., Gogoi R., Stark A. (2013) Sensible use of ICD-9 Diagnosis in Breast and Endometrial Cancer Research. Clin Med Res 11(3).
Role: study conception, design, implementation (including patient recruitment), data analysis, manuscript writing.

12. Peng W., Dunton C., Holtz D., Parva M*., Stampler K*., Forwood M., Gogoi R., Lace M., Anderson D., Sawicki J. (2013) DNA Nanotherapy for pre-neoplastic cervical lesions. Gynecologic Oncology 128 (1): 101-6. PMID: 23103931. *Ob/Gyn residents
Role: study conception, design, implementation (including patient recruitment), data analysis, manuscript writing.

13. Lande L., Peterson D., Gogoi R., Yankowski C., Stampler K.*, Kwait R., Daum G., Hauler K., Danley J., Sawicki K., Sawicki J. (2012) The Association between Pulmonary Mycobacterium Avium Complex Infection and Lung Cancer. J. Thoracic Oncology 7 (9): 1345-51. PMID: 22699888. *Ob/Gyn residents
Role: study conception, design, implementation (including patient recruitment), data analysis, manuscript writing.

14. Gogoi R., Urban R., Sun H., Goff B. (2012) Evaluation of Society of Gynecologic Oncologists (SGO) Ovarian Cancer Quality Surgical Measures. Gynecologic Oncology 126(2): 217-9. PMID: 22561039.
Role: study conception, design, implementation (including patient recruitment), data analysis, manuscript writing.

15. Gogoi R., Kudla M., Gil O., Fishman D. (2008) The activity of Medroxyprogesterone Acetate, an androgenic ligand, in ovarian cancer cell invasion. J. Repro Sciences 15(8): 846-52. PMID: 19017820
Role: study conception, design, implementation (including patient recruitment), data analysis, manuscript writing.

16. Bray J., Jelinsky S., Ghatge R., Bray J., Tunkey C., Saraf K., Jacobsen BM., Richer J., Brown E., Winneker R., Horwitz K B., Lyttle CR. (2005) Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action in T47D breast cancer cells. J. Steroid Biochem Mol Biol. 97. 328-341.
Role: study conception, design, implementation (including patient recruitment), data analysis, manuscript writing.

17. Ghatge R., Jacobsen B., Schittone S., Horwitz K. (2005) The progestational and androgenic properties of Medroxyprogesterone acetate: Gene regulatory overlap with Dihydrotestosterone in breast cancer cells. Breast Cancer Res. 7:1036-1050.
Role: study conception, design, implementation (including patient recruitment), data analysis, manuscript writing.

Case Reports

1. King, L., Gogoi, R.P., Hummel, C., Smith A. Malignant Brenner tumor: Two case reports. Case Rep Womens Health 2018 Oct 13

2. King, L., Gogoi, R.P., Hummel, C., Chen Z., Smith A. High Grade Uterine Sarcoma with concurrent metastatic adenocarcinoma to the uterus: A case report Obstet Gynecol Cases Rev 2018 5:127

3. Storm M., Kaspar H., Nash J., Gogoi R., Smith A. (2015) Mixed Epithelial and Germ Cell Ovarian Cancer. Women’s Health-Open Journal

4. Swenski J., Arceo-Mendoza R., Gogoi R., Signalov M. (2014) Parathyroid hormone independent hypercalcemia in the setting of non-metastatic leiomyosarcoma. Case Reports in Internal Medicine. 1(2).

5. Madueke-Laveaux O.S., Gogoi R., Stoner G. (2013) Giant Fibroepithelial stromal polyp of the vulva: largest case reported. Ann Surg Innov Res 7(1):8. PMID: 23842282

6. Dierking E., Gogoi R., Adamcik S., Greene L., Curtin J. (2008) Adrenal insufficiency following laparoscopic hysterectomy in a patient with primary antiphospholipid syndrome. Obstet Gynecol. 111:495-498.

Review Articles

1. Gogoi R., Srinavasan S., Fishman D. (2006) Progress in biomarker discovery for diagnostic testing in epithelial ovarian cancer. Expert Rev Mol Diagn 6(4): 627-637.


2. Ariztia EV., Lee C., Gogoi R., Fishman D.A. (2006) The tumor microenvironment: the key to early detection. Crit Rev Clin Lab Sci. 43: 393-425. PMID: 17050079

Book Authorships, Editorships, and Chapters

1. Lepley M, Ghatge R. Prenatal Environment. In: Merenstein G, Gardner S, editors. Handbook of Neonatal Intensive Care Handbook of Neonatal Intensive Care. 6th edition

2. Gogoi R, Fishman D. Ovarian Cancer Detection. In Lobo, R, editors. Treatment of the postmenopausal woman. 2006.

PRESENTATIONS

Podium Presentations (refereed)

1. Gogoi R., Ladd I., Larson S., Cervical Cancer patients understanding of HPV effect and their ability to serve as HPV educators. IGCS 2018.

2. Nagar P., Ladd I., Larson S., Gogoi R. Patients with cervical cancer serving as health care educators. Resident Research Scholarship days May 2017

3. Welshans K., Sun H., Nash J.D., Smith A., Gogoi R., Time is Money: Does IV Tylenol decrease time to discharge in patients robotic surgery for endometrial cancer. Resident Scholarship days May 2017.

4. Miller J., Shivakumar M., Dasari V., Gogoi R., Kim D. Survival analysis identifies germline variants associated with overall survival among an endometrial cancer cohort. TBC 2015.

5. Zhou Y., Cartmel B., Li F., Ercolano E., Harrigan M., McCorkle R., Ligibel JA., Von Gruenignen V., Gogoi R., Schwartz P., Risch H., Irwin M. Randomized trial of exercise and quality of life and fatigue in women diagnosed with ovarian cancer: The Women’s activity and lifestyle study in Connecticut. ASCO 2015.

6. Gogoi R., Sawicki J., HPV16 DNA-Based Nanotherapy for Cervical Cancer. SGO Annual meeting. March 2010.

Poster Presentations (refereed)

1. Verteporfin, A new chemotherapeutic option in ovarian cancer. IGCS 2018

2. Dasari R., Miller J., Kim D., Gogoi R. Verteporfin sensitizes endometrial cancer cells to radiation or chemotherapy treatment. SGO 2018

3. Gogoi R., Ladd I., Smith A., Nash J., Larson S. After the cervical cancer diagnosis, who’s talking about why? SGO 2018

4. Ladd I., Gogoi R., Larson S. Assessing cervical cancer patients’ willingness and ability to serve as health care educators to advocate for HPV vaccine uptake. HCSRN 2018

5. Miller J., Metpally R., Pearson TN., Krishnamurthy SB., Dasari VR., Lavage D., Cook A., Smith A., Nash JD., Carey DJ., Ritchie MD., Kim D., Gogoi R. Systematic characterization of germline variants in endometrial carcinoma from the DiscovEHR study. ASHG 2017

6. Gogoi R.P., Casteneda Gill, J., Metpally, R., Krishnamurthy S., Vishwanatha, J., Carey D., Nash D., Dasari V.R. Anti-proliferative and cytotoxic effects of Verteporfin in Endometrial cancer cells. AACR 2017

7. Loehr W., Gogoi R. Case of poorly differentiated ovarian adenocarcinoma metastasized to the pericardial space. Resident research scholarship days May 2017.

8. Dasari V., Mazack V., Carey D., Nash J., Gogoi R. Verteporfin- a new chemotherapeutic agent in endometrial cancer. SGO Annual Meeting. March 2017.

9. Welshans K., Walter G., Nash J., Smith A., Gogoi R. Time is money- does IV Tylenol decrease time to discharge in patients undergoing robotic surgery for endometrial cancer. SGO Annual Meeting. March 2017.

10. Kim C., Smith A., Nash J., Gogoi R. An opportunity to collaborate: An initiative with a university mechanical engineering program to design a new morcellating device. SGO Annual Meeting. March 2017.

11. Gogoi R., Tsujiura M., Mazack M., Carey D., Kaspar J., Nash J. Yes- associated protein as a therapeutic target in endometrial cancer. Keystone meeting. May 2015.

12. Rahm AK., Kip S., Guha S., Fan A., Kaspar H., Williams J., Gogoi R., Chen Z., Davis D., Williams M. Coordinating laboratory and clinical data to include endometrial tumor testing to the universal lynch syndrome screening program at Geisinger Health system. National Society of genetic counsellors 2015.

13. Rahm, A.K.; Kip, N.K.; Guha, S.; Fan, A.; Kaspar, H.G.; Williams J.L.; Gogoi, R.; Chen, Z; Davis, D.; Williams, M.S. Evaluation and optimization of a Universal Lynch Syndrome Screening program at Geisinger Health System. American Society of Human Genetics. October 2015 (Reviewers choice abstract)

14. Evaluation and improvement of a universal lynch syndrome screening program. Science of Dissemination and Implementation Conference. Dec 2015.

15. Implementing Precision Medicine: Universal Lynch Syndrome. ISERC 2016.

16. Tsujiura M., Mazack V., Sudol M., Kaspar H.G., Nash J., Carey D., Gogoi R. Yes-associated protein modulates oncogenic features and radiation sensitivity in endometrial cancer. SGO Annual Meeting. March 2014.

17. Gogoi R., Smith A., Sun H., Nash J. Cervical cancer screening history in elderly patients in a rural population. SGO Annual Meeting. March 2014.

18. Feng W., Yan X., Pritchard J., Gogoi R., Stark A. Sensible use of ICD-9 diagnostic codes of observational data in breast and endometrial cancer research. HMORN Annual Meeting. May 2013.

19. Butler M., Stark A., Kirchner L., Gogoi R., Leader J., Lewis M., Muggia F. Changes in Renal function following treatment for ovarian cancer. ASCO Annual Meeting. May 2013.

20. Bickley T., Sudol M., Mazack V., Sun H., Nash J., Kaspar H., Gogoi R. The Role of the Yes kinase-associated protein as a proto-oncogene in Endometrial Cancer. SGO Annual Meeting. March 2013.

21. Gogoi R., Urban R., Sun H., Goff B. Evaluation of the Society of Gynecologic Oncologists Quality Surgical Measures. SGO Annual Meeting . March 2012.

22. Sawicki J., Huang Y., Yeo CJ., Gogoi R., Love K., Anderson D.G., Witkiewicz A., Brody J. Nanotherapeutic silencing of HuR: Targeting a tumor-promoting response in ovarian cancer. AACR. April 2012.

23. Lande L., Gogoi R., Yankowski C., Stampler K., Sawicki K., Daum G., Peterson D., Sawicki J. The association between pulmonary Mycobacterium avium Complex infection and lung cancer in women. American Thoracic Society. May 2010.

24. Gogoi R., Kudla M., Gill O., Horwitz K., Fishman D. Is there a role for the Androgen receptor in ovarian cancer invasion. SGI Annual meeting. March 2007.

25. Gogoi R., Jacobsen B., Fishman D., Horwitz K. The role of the androgen receptor in breast and ovarian cancer. Marsha Rivkin ovarian cancer foundation. June 2006.

26. Gogoi R., Jacobsen B., Schittone S., Horwitz K. The protective role of the Androgen Receptor in breast cancer. SGO Annual meeting. March 2006.

Invited Lectures/Presentations

Invited Seminars and Grand Rounds

1. Geisinger Medical Center Grand Rounds “Management of Adnexal Mass” Danville, PA. September 2018.

2. Womens Health Update CME. Geisinger Medical Center Center “Management of Abnormal Uterine
Bleeding.” Danville, PA. September 2018.

3. University of Florida Grand Rounds, Gainesville, Florida. February 2015.

4. Rochester General Hospital Grand Rounds, Rochester, NY. November 2014

5. Riddle Hospital Grand Rounds, Media, PA. May 2009
 

 

Faculty Status

GYN-Onc

← Return to listing